{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:31Z","timestamp":1783606951467,"version":"3.55.0"},"reference-count":22,"publisher":"Bioscientifica","issue":"6","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,1]]},"abstract":"<jats:p>Pancreatic neuroendocrine tumors (PanNETs) are characterized by limited therapeutic options and frequent resistance to monotherapies such as everolimus. Targeting metabolic pathways alongside mTOR signaling may improve treatment efficacy. This study aimed to investigate the synergistic antitumor effects of orlistat, a fatty acid synthase inhibitor, combined with everolimus in PanNETs and to elucidate the underlying molecular mechanisms. In vitro assays, including CCK-8, colony formation, EdU incorporation, and western blotting, were performed on PanNET cell lines. In vivo efficacy and safety were evaluated using subcutaneous xenograft mouse models. Transcriptomic profiling and functional studies of SLFN5 were conducted to uncover its regulatory role in PI3K\/AKT\/mTOR signaling and drug response. Orlistat and everolimus exhibited a significant synergistic inhibitory effect on PanNET cell proliferation. The combination markedly suppressed tumor growth in vivo without evident toxicity. RNA sequencing revealed distinct transcriptomic changes and highlighted SLFN5 as a key downregulated gene in PanNETs. Functional assays demonstrated that SLFN5 overexpression inhibited tumor growth and enhanced drug sensitivity by negatively regulating the PI3K\/AKT\/mTOR pathway. Conversely, SLFN5 knockdown impaired the antitumor efficacy of the drug combination. In conclusion, the combination of orlistat and everolimus represents a promising therapeutic strategy for PanNETs, with SLFN5 serving as a critical mediator and potential biomarker for treatment efficacy.<\/jats:p>","DOI":"10.1530\/erc-25-0422","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:31:15Z","timestamp":1779298275000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Orlistat combined with everolimus suppresses pancreatic neuroendocrine tumor progression via inhibiting PI3K\/AKT\/mTOR signaling mediated by SLFN5"],"prefix":"10.1530","volume":"33","author":[{"given":"Lin","family":"Xu","sequence":"first","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengjuan","family":"Chen","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Tian","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Yan","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7822-7297","authenticated-orcid":true,"given":"Jianan","family":"Bai","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Long","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoya","family":"Li","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7731-9857","authenticated-orcid":true,"given":"Mujie","family":"Ye","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2408-7908","authenticated-orcid":true,"given":"Qiyun","family":"Tang","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2026070909475863700_bib1","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/cncr.23899","article-title":"Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study","volume":"113","author":"Rodriguez","year":"2008","journal-title":"Cancer"},{"key":"2026070909475863700_bib2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"2026070909475863700_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"2026070909475863700_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"2026070909475863700_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"2026070909475863700_bib6","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.cmet.2019.10.007","article-title":"Selective persulfide detection reveals evolutionarily conserved antiaging effects of S-sulfhydration","volume":"30","author":"Zivanovic","year":"2019","journal-title":"Cell Metab"},{"key":"2026070909475863700_bib7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.2217\/fon.10.21","article-title":"New insights into the mechanisms of gastric cancer multidrug resistance and future perspectives","volume":"6","author":"Zhang","year":"2010","journal-title":"Future Oncol"},{"key":"2026070909475863700_bib8","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.7150\/jca.83118","article-title":"Orlistat induces ferroptosis in pancreatic neuroendocrine tumors by inactivating the MAPK pathway","volume":"14","author":"Ye","year":"2023","journal-title":"J Cancer"},{"key":"2026070909475863700_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nrc2223","article-title":"The emerging roles of forkhead box (Fox) proteins in cancer","volume":"7","author":"Myatt","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2026070909475863700_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2026070909475863700_bib11","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.3390\/cancers11121907","article-title":"Proteogenomics of colorectal cancer liver metastases: complementing precision oncology with phenotypic data","volume":"11","author":"Blank-Landeshammer","year":"2019","journal-title":"Cancers"},{"key":"2026070909475863700_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.canlet.2020.02.011","article-title":"COPZ1 depletion in thyroid tumor cells triggers type I IFN response and immunogenic cell death","volume":"476","author":"Di Marco","year":"2020","journal-title":"Cancer Lett"},{"key":"2026070909475863700_bib13","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/cr.2017.130","article-title":"White adipose tissue coloring by intermittent fasting","volume":"27","author":"Kivel\u00e4","year":"2017","journal-title":"Cell Res"},{"key":"2026070909475863700_bib14","doi-asserted-by":"crossref","first-page":"26422","DOI":"10.18632\/oncotarget.8389","article-title":"Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"2026070909475863700_bib15","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.jid.2019.04.006","article-title":"Intervention of inflammatory monocyte activity limits dermal fibrosis","volume":"139","author":"Haub","year":"2019","journal-title":"J Invest Dermatol"},{"key":"2026070909475863700_bib16","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.bbrc.2018.05.104","article-title":"UCA1 confers paclitaxel resistance to ovarian cancer through miR-129\/ABCB1 axis","volume":"501","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"2026070909475863700_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/ccs3.12041","article-title":"Hypoxia drives CBR4 down-regulation promotes gastroenteropancreatic neuroendocrine tumors via activation mammalian target of rapamycin mediated by fatty acid synthase","volume":"18","author":"Ye","year":"2024","journal-title":"J Cell Commun Signal"},{"key":"2026070909475863700_bib18","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402990R","article-title":"CEP55, a promising prognostic biomarker for pancreatic neuroendocrine neoplasms, promotes tumor progression through activation of PI3K\/AKT\/mTOR pathway","volume":"39","author":"Xu","year":"2025","journal-title":"FASEB J"},{"key":"2026070909475863700_bib19","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1111\/cas.15883","article-title":"FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt\/\u03b2-catenin pathway","volume":"114","author":"Lu","year":"2023","journal-title":"Cancer Sci"},{"key":"2026070909475863700_bib20","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.7150\/ijbs.103428","article-title":"FTO -induced APOE promotes the malignant progression of pancreatic neuroendocrine neoplasms through FASN -mediated lipid metabolism","volume":"21","author":"Chen","year":"2025","journal-title":"Int J Biol Sci"},{"key":"2026070909475863700_bib21","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.7150\/ijbs.85285","article-title":"FABP5 suppresses colorectal cancer progression via mTOR-mediated autophagy by decreasing FASN expression","volume":"19","author":"Ye","year":"2023","journal-title":"Int J Biol Sci"},{"key":"2026070909475863700_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12967-024-04870-z","article-title":"Hypoxia upregulating ACSS2 enhances lipid metabolism reprogramming through HMGCS1 mediated PI3K\/AKT\/mTOR pathway to promote the progression of pancreatic neuroendocrine neoplasms","volume":"22","author":"Gu","year":"2024","journal-title":"J Transl Med"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/6\/ERC-25-0422.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/6\/ERC-25-0422.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0422\/520438\/erc-25-0422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0422\/520438\/erc-25-0422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:48:07Z","timestamp":1783604887000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/6\/e250422\/77642\/Orlistat-combined-with-everolimus-suppresses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0422","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"e250422"}}